Target Name: MIR3679
NCBI ID: G100500878
Review Report on MIR3679 Target / Biomarker Content of Review Report on MIR3679 Target / Biomarker
MIR3679
Other Name(s): hsa-miR-3679-3p | MicroRNA 3679 | hsa-mir-3679 | microRNA 3679 | hsa-miR-3679-5p | mir-3679

MIR3679: A Drug Target / Disease Biomarker

MIR3679, also known as interleukin-3679, is a protein that is expressed in various tissues throughout the body. It is a member of the interleukin-3 family, which is a group of cytokines that play a crucial role in the immune system. MIR3679 has been shown to have various biological functions, including regulating inflammation, promoting tissue repair, and influencing cellular signaling pathways. As a result, MIR3679 has potential as a drug target or biomarker in a variety of diseases.

One of the key functions of MIR3679 is its role in inflammation regulation. MIR3679 has been shown to play a negative role in the regulation of inflammatory responses. Specifically, MIR3679 has been shown to reduce the production of pro-inflammatory cytokines, such as TNF-伪, IL-1尾, and IL-6, by suppressing the activity of the nuclear factor kappa B (NFKB) signaling pathway. This is important because chronic inflammation can contribute to a variety of diseases, including heart disease, cancer, and autoimmune disorders.

Another function of MIR3679 is its role in tissue repair and regeneration. MIR3679 has been shown to promote the production of pro-regenerative cytokines, such as PDGF-尾, by suppressing the activity of the transforming growth factor-尾 (TGF-β) signaling pathway. This is important because TGF-β is a key player in the regulation of cellular processes that are critical for tissue repair and regeneration, including wound healing, skin repair, and neural regeneration.

MIR3679 has also been shown to play a role in cellular signaling pathways that are important for cell survival and proliferation. For example, MIR3679 has been shown to promote the production of the anti-apoptotic protein Bcl-2 by suppressing the activity of the extrinsic factor-binding protein (EFP) signaling pathway. This is important because Bcl-2 is a key protein that can protect cells from apoptosis, which is a critical mechanism that regulates cell death.

In addition to its functions in inflammation, tissue repair, and cellular signaling pathways, MIR3679 has also been shown to have potential as a drug target or biomarker in a variety of diseases. For example, MIR3679 has been shown to be a potential therapeutic target for cancer, including breast cancer, because it has been shown to promote the growth and survival of cancer cells. Additionally, MIR3679 has been shown to be a potential biomarker for a variety of diseases, including heart disease, because it has been shown to be decreased in the hearts of individuals with certain conditions, such as heart failure and myocardial infarction.

Overall, MIR3679 is a protein that has potential as a drug target or biomarker in a variety of diseases. Its functions in inflammation, tissue repair, and cellular signaling pathways make it an attractive target for further research, and its potential as a therapeutic or diagnostic agent makes it an important area of study. Further research is needed to fully understand the role of MIR3679 in disease and to develop effective treatments or diagnostic tools based on its properties.

Protein Name: MicroRNA 3679

The "MIR3679 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3679 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR3680-1 | MIR3680-2 | MIR3681 | MIR3681HG | MIR3682 | MIR3683 | MIR3685 | MIR3686 | MIR3687 | MIR3688-1 | MIR3688-2 | MIR3689A | MIR3689B | MIR3689C | MIR3689D1 | MIR3689D2 | MIR3689F | MIR369 | MIR3690 | MIR3691 | MIR3692 | MIR370 | MIR3713 | MIR3714 | MIR371A | MIR371B | MIR372 | MIR373 | MIR374A | MIR374B | MIR374C | MIR375 | MIR376A1 | MIR376A2 | MIR376B | MIR376C | MIR377 | MIR378A | MIR378B | MIR378C | MIR378D1 | MIR378D2 | MIR378E | MIR378F | MIR378G | MIR378H | MIR378I | MIR379 | MIR380 | MIR381 | MIR382 | MIR383 | MIR384 | MIR3907 | MIR3908 | MIR3909 | MIR3910-1 | MIR3910-2 | MIR3911 | MIR3912 | MIR3913-1 | MIR3913-2 | MIR3914-1 | MIR3914-2 | MIR3915 | MIR3916 | MIR3917 | MIR3918 | MIR3919 | MIR3920 | MIR3921 | MIR3922 | MIR3923 | MIR3924 | MIR3925 | MIR3926-1 | MIR3926-2 | MIR3927 | MIR3928 | MIR3929 | MIR3934 | MIR3935 | MIR3936 | MIR3936HG | MIR3937 | MIR3938 | MIR3939 | MIR3940 | MIR3941 | MIR3942 | MIR3943 | MIR3944 | MIR3945 | MIR3945HG | MIR3960 | MIR3972 | MIR3973 | MIR3974 | MIR3976 | MIR3976HG